The closing price of Exscientia Plc ADR (NASDAQ: EXAI) was $5.72 for the day, down -1.04% from the previous closing price of $5.78. On the day, 503373 shares were traded.
Ratios:
Our analysis of EXAI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.22 and its Current Ratio is at 6.22. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on January 05, 2024, Downgraded its rating to Neutral and sets its target price to $9 from $11 previously.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXAI now has a Market Capitalization of 721.40M and an Enterprise Value of 289.64M. For the stock, the TTM Price-to-Sale (P/S) ratio is 28.74 while its Price-to-Book (P/B) ratio in mrq is 1.59. Its current Enterprise Value per Revenue stands at 14.42 whereas that against EBITDA is -1.99.
Stock Price History:
The Beta on a monthly basis for EXAI is 0.79, which has changed by 9.37% over the last 52 weeks, in comparison to a change of 27.39% over the same period for the S&P500. Over the past 52 weeks, EXAI has reached a high of $9.12, while it has fallen to a 52-week low of $4.17. The 50-Day Moving Average of the stock is 6.20, while the 200-Day Moving Average is calculated to be 6.11.
Shares Statistics:
EXAI traded an average of 746.79K shares per day over the past three months and 529.64k shares per day over the past ten days. A total of 125.70M shares are outstanding, with a floating share count of 117.93M. Insiders hold about 6.18% of the company’s shares, while institutions hold 19.03% stake in the company. Shares short for EXAI as of Mar 15, 2024 were 3.77M with a Short Ratio of 5.05, compared to 3.77M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.99% and a Short% of Float of 6.21%.
Earnings Estimates
The firm’s stock currently is rated by 2 analysts. On average, analysts expect EPS of -$0.37 for the current quarter, with a high estimate of -$0.36 and a low estimate of -$0.39, while EPS last year was -$0.38. The consensus estimate for the next quarter is -$0.32, with high estimates of -$0.24 and low estimates of -$0.4.
Analysts are recommending an EPS of between -$0.74 and -$1.76 for the fiscal current year, implying an average EPS of -$1.37. EPS for the following year is -$1.42, with 3 analysts recommending between -$1 and -$1.7.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 2 analysts. It ranges from a high estimate of $10.12M to a low estimate of $5M. As of the current estimate, Exscientia Plc ADR’s year-ago sales were $7.1M, an estimated increase of 6.50% from the year-ago figure. For the next quarter, 2 analysts are estimating revenue of $15.16M, an increase of 296.90% over than the figure of $6.50% in the same quarter last year. There is a high estimate of $25.31M for the next quarter, whereas the lowest estimate is $5M.
A total of 3 analysts have provided revenue estimates for EXAI’s current fiscal year. The highest revenue estimate was $126.38M, while the lowest revenue estimate was $20M, resulting in an average revenue estimate of $58.18M. In the same quarter a year ago, actual revenue was $25.6M, up 127.30% from the average estimate.
